Literature DB >> 1548083

Adherence of enterohemorrhagic Escherichia coli strains to a human colonic epithelial cell line (T84).

D K Winsor1, S Ashkenazi, R Chiovetti, T G Cleary.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) produce Shiga-like toxins and attach to certain tissue culture cells. T84 cells are human colonic carcinoma cells. Unlike previously studied cell lines, T84 cells grown on collagen-coated surfaces polarize and produce tight junctions and desmosomes, forming a colonic epithelial cell layer in vitro. The purpose of this study was to examine the attachment of EHEC strains to the T84 cell line as a possibly more relevant in vitro model of EHEC adherence. Twelve EHEC strains were grown overnight in Penassay broth, suspended in minimal essential medium with and without 0.5% mannose, and incubated for 1 to 3 h with 5- to 7-day-old T84 cell monolayers grown on collagen-coated coverslips. The bacteria were removed, and attachment was quantitated microscopically. For both E. coli O157:H7 and other EHEC serotypes, there were marked differences in adherence between strains (range of 152 to 3 bacteria per oil immersion field). Mannose partially inhibited the adherence of some EHEC strains. Adherence to the T84 cells appeared to be related to the amount of pili present and not to the serotype. Electron micrographs showed that a highly adherent strain (strain 43-12) tended to form microcolonies in the area of tight junctions on the T84 cell monolayers. In addition, the attachment of these EHEC strains to T84 cells correlated with their ability to adhere to isolated rabbit colonocytes (r = 0.91, P = 0.00004; without mannose) (r = 0.60, P = 0.04; with mannose). These data show that there are EHEC strain-related differences in adherence which can be demonstrated in a human-derived colonic epithelial cell line (T84) and that these cells can be used to study EHEC adherence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548083      PMCID: PMC257037          DOI: 10.1128/iai.60.4.1613-1617.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism?

Authors:  J Holmgren; J Fryklund; H Larsson
Journal:  Scand J Immunol       Date:  1989-10       Impact factor: 3.487

2.  Inhibition of mucin secretion in a colonic adenocarcinoma cell line by DIDS and potassium channel blockers.

Authors:  M A Marcon; D McCool; J Forstner; G Forstner
Journal:  Biochim Biophys Acta       Date:  1990-04-09

Review 3.  The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.

Authors:  K L Audus; R L Bartel; I J Hidalgo; R T Borchardt
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

4.  Outer membranes are competitive inhibitors of Escherichia coli O157:H7 adherence to epithelial cells.

Authors:  P Sherman; F Cockerill; R Soni; J Brunton
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

Authors:  S E Richardson; M A Karmali; L E Becker; C R Smith
Journal:  Hum Pathol       Date:  1988-09       Impact factor: 3.466

6.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

7.  Attaching and effacing adherence of Vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo.

Authors:  P Sherman; R Soni; M Karmali
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives.

Authors:  I Toth; M L Cohen; H S Rumschlag; L W Riley; E H White; J H Carr; W W Bond; I K Wachsmuth
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

10.  Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin.

Authors:  S U Sajjan; J F Forstner
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

View more
  12 in total

1.  Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions.

Authors:  Z Li; E Elliott; J Payne; J Isaacs; P Gunning; E V O'loughlin
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 3.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli.

Authors:  A Ismaili; D J Philpott; M T Dytoc; P M Sherman
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Alfredo G Torres; Jorge A Giron; Nicole T Perna; Valerie Burland; Fred R Blattner; Fabiola Avelino-Flores; James B Kaper
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract.

Authors:  Rachel R Spurbeck; Paul C Dinh; Seth T Walk; Ann E Stapleton; Thomas M Hooton; Lisa K Nolan; Kwang Sik Kim; James R Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

8.  Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.

Authors:  Stephanie Dahan; Guillaume Dalmasso; Veronique Imbert; Jean-Francois Peyron; Patrick Rampal; Dorota Czerucka
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Virulence of an Escherichia coli O157:H7 sorbitol-positive mutant.

Authors:  P M Fratamico; R L Buchanan; P H Cooke
Journal:  Appl Environ Microbiol       Date:  1993-12       Impact factor: 4.792

10.  Intracellular activity of azithromycin against bacterial enteric pathogens.

Authors:  R M Rakita; K Jacques-Palaz; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.